AHA today urged the United States Pharmacopeial Convention to delay by at least 18 months the effective dates for its general chapter <797> pharmaceutical compounding and general chapter <800> hazardous drug handling in health care settings, as well as proposed revisions to general chapter <797>. “USP guidelines play a critical role in keeping our hospital staffs and the patients they care for safe,” AHA wrote. “However, we reiterate concerns we have previously shared regarding the compliance challenges that these two sections create.” Specifically, the proposed changes to general chapter <797> may impact or modify efforts by hospitals and health systems to comply with chapter <800>; the guidelines involve large capital investments, in some cases the construction of entirely new buildings; and the timeline has resulted in high demand for contractors and supplies, making it very challenging for all facilities to comply by the effective date, AHA said. The association also commended USP for simplifying many provisions in its September redraft of general chapter <797>, but shared some concerns regarding the beyond-use dates, repackaging and temperature metrics.  
 

Related News Articles

Webinar Recordings
Member
The final rule updates physician fee schedule payments for CY 2019 and finalizes several policies to implement year three of the Quality Payment Program…
Advisory
Member
Download the full Regulatory Advisory (PDF) below
Advisory
Member
Download the Advisory as a PDF below. The Centers for Medi
Advisory
Member
October 10, 2018
Special Bulletin
Member
The Department of Homeland Security (DHS) Sept. 22 announced a proposed rule that could limit legal immigrants’ future immigration status, such as ability to…
Special Bulletin
Member